品田光洋 (Mitsuhiro Shinada) - マイポータル

基本情報

ORCID iD: https://orcid.org/0000-0003-4244-8914
J-GLOBAL ID: 202401016078090250
researchmap会員ID: R000070472

研究キーワード

研究分野

論文

Local therapy with hypoxia-targeting radiopharmaceutical [64Cu]Cu-ATSM in high-grade glioma patient-derived xenograft models.

Yukie Yoshii, Fukiko Hihara, Hiroki Matsumoto, Chika Igarashi, Tomoko Tachibana, Mitsuhiro Shinada, Makoto Ohtake, Hisashi Suzuki, Ming-Rong Zhang, Akito Oshima …

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 214 111325-111325 2026年1月
64Cu2+ Complexes of Tripodal Amine Ligands’ In Vivo Tumor and Liver Uptakes and Intracellular Cu Distribution in the Extrahepatic Bile Duct Carcinoma Cell Line TFK-1: A Basic Comparative Study

Mitsuhiro Shinada, Masashi Takahashi, Chika Igarashi, Hiroki Matsumoto, Fukiko Hihara, Tomoko Tachibana, Masakazu Oikawa, Hisashi Suzuki, Ming-Rong Zhang, Tatsuya Higashi …

Pharmaceuticals 2024年6月21日
Trace Metal Impurities Effects on the Formation of [64Cu]Cu-diacetyl-bis(N4-methylthiosemicarbazone) ([64Cu]Cu-ATSM).

Mitsuhiro Shinada, Hisashi Suzuki, Masayuki Hanyu, Chika Igarashi, Hiroki Matsumoto, Masashi Takahashi, Fukiko Hihara, Tomoko Tachibana, Chizuru Sogawa, Ming-Rong Zhang …

Pharmaceuticals (Basel, Switzerland) 17(1) 2023年12月21日
An In Vivo Dual-Observation Method to Monitor Tumor Mass and Tumor-Surface Blood Vessels for Developing Anti-Angiogenesis Agents against Submillimeter Tumors.

Tomoko Tachibana, Tomoko Gowa Oyama, Yukie Yoshii, Fukiko Hihara, Chika Igarashi, Mitsuhiro Shinada, Hiroki Matsumoto, Tatsuya Higashi, Toshihiko Kishimoto, Mitsumasa Taguchi

International journal of molecular sciences 24(24) 2023年12月7日
Process to Remove the Size Variants Contained in the Antibody-Chelator Complex PCTA-NCAB001 for Radiolabeling with Copper-64.

Yukie Yoshii, Hiroki Matsumoto, Chika Igarashi, Tomoko Tachibana, Fukiko Hihara, Mitsuhiro Shinada, Atsuo Waki, Sei Yoshida, Kenichiro Naito, Kimiteru Ito …

Pharmaceuticals (Basel, Switzerland) 16(10) 2023年9月22日
Preclinical Safety Evaluation of Intraperitoneally Administered Cu-Conjugated Anti-EGFR Antibody NCAB001 for the Early Diagnosis of Pancreatic Cancer Using PET.

Hiroki Matsumoto, Chika Igarashi, Tomoko Tachibana, Fukiko Hihara, Mitsuhiro Shinada, Atsuo Waki, Sei Yoshida, Kenichiro Naito, Hiroaki Kurihara, Makoto Ueno …

Pharmaceutics 14(9) 2022年9月12日
In Vitro Tumor Cell-Binding Assay to Select High-Binding Antibody and Predict Therapy Response for Personalized 64Cu-Intraperitoneal Radioimmunotherapy against Peritoneal Dissemination of Pancreatic Cancer: A Feasibility Study.

Fukiko Hihara, Hiroki Matsumoto, Mitsuyoshi Yoshimoto, Takashi Masuko, Yuichi Endo, Chika Igarashi, Tomoko Tachibana, Mitsuhiro Shinada, Ming-Rong Zhang, Gene Kurosawa …

International journal of molecular sciences 23(10) 2022年5月22日
Evaluation of Aminopolycarboxylate Chelators for Whole-Body Clearance of Free 225Ac: A Feasibility Study to Reduce Unexpected Radiation Exposure during Targeted Alpha Therapy.

Mitsuyoshi Yoshimoto, Yukie Yoshii, Hiroki Matsumoto, Mitsuhiro Shinada, Masashi Takahashi, Chika Igarashi, Fukiko Hihara, Tomoko Tachibana, Ayano Doi, Tatsuya Higashi …

Pharmaceutics 13(10) 2021年10月16日

MISC

225 Ac治療薬剤開発に資する遊離225Ac除去法の基礎研究

品田光洋

NLだより (535) 2-2 2022年7月

講演・口頭発表等

Evaluations for quality management of metal impurities in [64Cu]Cu-diacetyl-bis(N4-methylthiosemicarbazone) ([64Cu]Cu-ATSM) as a radiopharmaceutical

M. Shinada, H. Suzuki, M. Hanyu, C. Igarashi, H. Matsumoto, M. Takahashi, F. Hihara, T. Tachibana, C. Sogawa, M. Zhang, T. Higashi, H. Sato, H. Kurihara, Y. Yoshii, Y. Doi

EANM'24 - Annual Congress of the European Association of Nuclear Medicine
標的α線治療における遊離225Ac除去剤に関する⽣物無機化学的検討

品田光洋

⼤洗・アルファ合同研究会 2022年 2022年9月29日
標的α線治療における遊離225Ac除去に関する錯体化学的検討

品田光洋, 吉本, 光喜, 吉井, 幸恵, 松本, 博樹高橋, 正五十嵐, 千佳, 檜原, 扶紀子, 立花, 知子, 土井あや, の東達也, 藤井, 博史, 鷲山幸信

日本放射化学会第66回討論会
Radiochemical and pharmacokinetic studies of aminopolycarboxylate chelators to remove unexpectedly accumulated free 225Ac in the liver and whole body for targeted alpha therapy

Mitsuhiro Shinada, Mitsuyoshi Yoshimoto, Hiroki Matsumoto, Masashi Takahashi, Chika Igarashi, Fukiko Hihara, Tomoko Tachibana, Koshin Washiyama, Yukie Yoshii

The 13th Congress of the World Federation of Nuclear Medicine and Biology (WFNMB2022)

品田光洋

基本情報

研究キーワード

研究分野

論文

MISC

講演・口頭発表等

メニュー

共著者の一覧